Printed from Voxsanity (voxsanity.com.au) — NCT06935591 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Atrial Fibrillation
Atrial Fibrillation Trial, Recruiting
NCT06935591
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with persistent (but not long-standing) atrial fibrillation (an irregular heart rhythm), or recurring atrial fibrillation, as defined by this study's criteria.
- People who have recent heart electrical activity recordings (ECGs) from their atrial fibrillation, captured on specific approved recording systems, available in digital format.
- People whose medical records contain, or can confirm before the procedure, certain details about their atrial fibrillation — including the type, the size and shape of the heart's upper chambers, and any previous ablation treatments they have had (confirm with trial site).
- People who are 22 years of age or older at the time of enrolling in the study.
- People for whom a doctor has determined that a heart ablation procedure is medically appropriate.
- People who are willing and able to follow the study's requirements and have been fully informed about the nature of the study.
Who may not be able to join:
- People who have heart rhythm problems other than the types of atrial fibrillation defined by this study, including long-standing persistent atrial fibrillation that has lasted one year or more since diagnosis.
- People for whom a suitable ECG recording cannot be obtained before or during the ablation procedure, or whose ECG recordings are of insufficient quality.
- People who are already taking part in another clinical trial involving an investigational drug or device, or who plan to do so during this study.
- People who have a known or suspected medical condition that the treating doctor believes may put them at risk by participating in this study.
- People who are confirmed to be pregnant, according to the hospital's standard pre-surgery checks.
- People who have previously had a pulmonary vein isolation procedure, where all four pulmonary veins are confirmed to already be isolated based on electrical readings taken during the study procedure.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Vektor Medical
Registry
ClinicalTrials.gov
Start date
27 June 2025
Est. completion
1 October 2027
Where this trial is recruiting
🇩🇪 Germany
🇺🇸 United States
Primary endpoints
Freedom from AF
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.